Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talazoparib Maintenance in Malignant Mesothelioma
NCT04462809Phase 2Unknown
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of talazoparib in malignant pleural mesothelioma (MPM), malignant peritoneal mesothelioma (MPM), sponsored by Hospices Civils de Lyon. Status: unknown.
02
Drugs
talazoparib
03
Conditions
malignant pleural mesothelioma (MPM)malignant peritoneal mesothelioma (MPM)
Beyond the preview
Go deeper on NCT04462809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462809.